Extracorporeal membrane oxygenation (ECMO) is emerging as an alternative to ventilators for patients whose respiratory function is compromised.

Article: While no official consensus or formal guidelines have been established on the efficacy of ECMO in Covid-19 patients, some providers have experienced success using the therapy. Cardiothoracic & Vascular Surgical Associates (CTVSA), a private physician practice that works with 12 hospitals across the Chicago area, has supported more than 70 Covid-19 patients using ECMO with a mortality rate of about 10%.

Article by: Daniel Roza